Literature DB >> 11789869

Successful erbium: YAG laser-induced chorioretinal venous anastomosis for the management of ischemic central retinal vein occlusion. A report of two cases.

H Quiroz-Mercado1, E Sánchez-Buenfil, J L Guerrero-Naranjo, D Ochoa-Contreras, M Ruiz-Cruz, G Marcellino, D J Damico.   

Abstract

BACKGROUND: Central retinal vein occlusion (CRVO) is a disorder with potentially blinding complications, particularly when associated with retinal ischemia. There is no reliable treatment for ischemic CRVO.
METHODS: We developed a new approach for ischemic cases of CRVO consisting of vitrectomy, posterior hyaloid detachment, and four erbium:YAG laser-induced chorioretinal anastomoses, one in each quadrant.
RESULTS: We report two cases of ischemic CRVO treated with this approach, with initial visual acuity of count fingers at 30 cm and hand movements respectively. After the surgery, there was resolution of hemorrhages and macular edema and visual improvement to 20/400 in the first case and to 20/180 in the second case. In both cases, there was successful creation of chorioretinal anastomoses, and there was no anterior segment neovascularization or other complications related to the surgery.
CONCLUSION: This treatment shows promise in the management of the ischemic cases of CRVO, and further evaluation is justified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11789869     DOI: 10.1007/s004170100338

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  4 in total

1.  Laser induced chorioretinal venous anastomosis in ischaemic central retinal vein occlusion.

Authors:  A K H Kwok; V Y W Lee; T Y Y Lai; C Hon
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

2.  Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial.

Authors:  A Mirshahi; R Roohipoor; A Lashay; S F Mohammadi; M R Mansouri
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

3.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

4.  Practical management of retinal vein occlusions.

Authors:  Carlo La Spina; Umberto De Benedetto; Maurizio Battaglia Parodi; Gabriel Coscas; Francesco Bandello
Journal:  Ophthalmol Ther       Date:  2012-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.